Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- SciLifeLab
- Technical University of Denmark
- University of Utah
- The Ohio State University
- ;
- Nature Careers
- The University of Chicago
- University of Groningen
- University of Nottingham
- ; Swansea University
- ; University of Bradford
- AALTO UNIVERSITY
- Swinburne University of Technology
- University of British Columbia
- ; Bangor University
- ; The University of Edinburgh
- ; University of Limerick
- ; University of Nottingham
- ; University of Sussex
- ; University of Warwick
- Ageing better colab
- California Institute of Technology
- Crohn’s & Colitis Australia IBD PhD Scholarship
- Curtin University
- Erasmus University Rotterdam
- Friedrich Schiller University Jena •
- Ghent University
- KNAW
- Linköping University
- MASARYK UNIVERSITY
- Max Planck Institute for Molecular Genetics •
- Monash University
- National Institute for Bioprocessing Research and Training (NIBRT)
- Oak Ridge National Laboratory
- Rutgers University
- UiT The Arctic University of Norway
- Umeå University
- University of Basel
- University of Birmingham
- University of Copenhagen
- University of Maryland, Baltimore
- University of Michigan
- University of Minnesota
- University of Minnesota Twin Cities
- University of South Carolina
- University of Stavanger
- 36 more »
- « less
-
Field
-
We invite applications for a PhD position in computer-aided drug design at the Computational Pharmacy Group, Department of Pharmaceutical Sciences, University of Basel. This position is part of
-
peptides, including the design of de novo sequences based on the elucidated mechanism. The first step will be to develop a computational approach to determine the critical peptide properties required
-
This PhD project aims to advance Safe and Sustainable by Design (SSbD) pharmaceutical manufacturing by integrating cutting-edge methodologies, including computer-assisted retrosynthesis, end-to-end
-
to analyse complex datasets, extract meaningful insights, and guide the optimisation of drug molecules. Collaborate with internal groups, including the Centre for Additive Manufacturing (CfAM) to design and
-
to analyse complex datasets, extract meaningful insights, and guide the optimisation of drug molecules. Collaborate with internal groups, including the Centre for Additive Manufacturing (CfAM) to design and
-
The project aims to develop a publicly accessible in silico database that identifies and catalogues bacterial genes capable of altering the effectiveness of chemotherapy drugs in colorectal cancer
-
, coronaviruses, influenza, pneumonia, RSV) as well as pollution, tobacco, pollen, weather, drugs, foods and stinging insects. The long-term plan for the Driver Programme is to extend the data science capabilities
-
Drug-resistant fungal infections—caused by species like Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus—pose a growing threat in healthcare, with mortality rates exceeding 50% in